342 related articles for article (PubMed ID: 34445587)
1. PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery.
Butreddy A; Gaddam RP; Kommineni N; Dudhipala N; Voshavar C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445587
[TBL] [Abstract][Full Text] [Related]
2. Quality by design thinking in the development of long-acting injectable PLGA/PLA-based microspheres for peptide and protein drug delivery.
Zhang C; Yang L; Wan F; Bera H; Cun D; Rantanen J; Yang M
Int J Pharm; 2020 Jul; 585():119441. PubMed ID: 32442645
[TBL] [Abstract][Full Text] [Related]
3. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
Ma G
J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
[TBL] [Abstract][Full Text] [Related]
4. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP
Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463
[TBL] [Abstract][Full Text] [Related]
5. Tunable sustained release drug delivery system based on mononuclear aqueous core-polymer shell microcapsules.
Abulateefeh SR; Alkawareek MY; Alkilany AM
Int J Pharm; 2019 Mar; 558():291-298. PubMed ID: 30641178
[TBL] [Abstract][Full Text] [Related]
6. Effect of mPEG-PLGA on Drug Crystallinity and Release of Long-Acting Injection Microspheres: In Vitro and In Vivo Perspectives.
Xing D; Tang L; Yang H; Yan M; Yuan P; Wu Y; Zhang Y; Yin T; Wang Y; Gou J; Tang X; He H
Pharm Res; 2024 Jun; 41(6):1271-1284. PubMed ID: 38839720
[TBL] [Abstract][Full Text] [Related]
7. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.
Kostanski JW; Thanoo BC; DeLuca PP
Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259
[TBL] [Abstract][Full Text] [Related]
9. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
[TBL] [Abstract][Full Text] [Related]
10. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres.
Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
J Control Release; 2019 Aug; 308():1-13. PubMed ID: 31301338
[TBL] [Abstract][Full Text] [Related]
11. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
12. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
[TBL] [Abstract][Full Text] [Related]
13. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP
Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.
Xu FH; Zhang Q
Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
16. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
[TBL] [Abstract][Full Text] [Related]
17. Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres.
Li T; Chandrashekar A; Beig A; Walker J; Hong JKY; Benet A; Kang J; Ackermann R; Wang Y; Qin B; Schwendeman AS; Schwendeman SP
Eur J Pharm Biopharm; 2021 Jan; 158():401-409. PubMed ID: 33122118
[TBL] [Abstract][Full Text] [Related]
18. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics.
Shao PG; Bailey LC
Pharm Dev Technol; 2000; 5(1):1-9. PubMed ID: 10669912
[TBL] [Abstract][Full Text] [Related]
19. Dry fabrication of poly(dl-lactide-co-glycolide) microspheres incorporating a medium molecular drug by a ball mill method.
Matsumoto A; Murakami M
Drug Discov Ther; 2021 Mar; 15(1):20-27. PubMed ID: 33627576
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres.
Blanco-Príeto MJ; Besseghir K; Zerbe O; Andris D; Orsolini P; Heimgartner F; Merkle HP; Gander B
J Control Release; 2000 Jun; 67(1):19-28. PubMed ID: 10773325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
